| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJO.2004.04.022 |
| P698 | PubMed publication ID | 15364220 |
| P50 | author | Robert N Weinreb | Q46195077 |
| Daniel F. Kripke | Q59275357 | ||
| P2093 | author name string | John H K Liu | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | latanoprost | Q634959 |
| P304 | page(s) | 389-395 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure | |
| P478 | volume | 138 |
| Q26766594 | 24-h Efficacy of Glaucoma Treatment Options |
| Q57381952 | Advances in the topical ocular drug delivery |
| Q46665750 | Analysis of 24-Hour IOP-related Pattern Changes After Medical Therapy |
| Q33886940 | Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community |
| Q42125423 | Circadian intraocular pressure profiles in chronic open angle glaucomas |
| Q37320388 | Circadian variation of aqueous humor dynamics in older healthy adults. |
| Q35761456 | Circadian variations in central corneal thickness and intraocular pressure in patients with glaucoma |
| Q33785986 | Contralateral intraocular pressure lowering effect of prostaglandin analogues |
| Q57807191 | Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment |
| Q36352369 | Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor |
| Q41860908 | Effect of timolol maleate gel-forming solution on intraocular pressure, pupil diameter, and heart rate in normal and glaucomatous cats |
| Q35814361 | Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial |
| Q55018791 | Effects of Topical Latanoprost on Intraocular Pressure and Myopia Progression in Young Guinea Pigs. |
| Q42551752 | Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients. |
| Q91781552 | Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis |
| Q55192535 | Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy. |
| Q84120625 | Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy |
| Q37847182 | Emerging drugs for ocular hypertension |
| Q34775032 | Evaluation of a contact lens-embedded sensor for intraocular pressure measurement |
| Q38002373 | Geriatric vision loss due to cataracts, macular degeneration, and glaucoma |
| Q35079342 | Glaucoma management: relative value and place in therapy of available drug treatments |
| Q53555670 | Glaucoma-Intraocular Pressure Reduction. |
| Q33307040 | Glaucoma: a review of adjunctive therapy and new management strategies |
| Q98945306 | Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism |
| Q34452693 | Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study |
| Q27014089 | Is 24-hour intraocular pressure monitoring necessary in glaucoma? |
| Q45991237 | Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings. |
| Q38018840 | Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma |
| Q42683473 | Optimal sampling scheme for estimation of intraocular pressure diurnal curves in glaucoma trials |
| Q35925020 | Prevention of nocturnal elevation of intraocular pressure by gene transfer of dominant-negative RhoA in rats |
| Q37444732 | Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety |
| Q33596855 | Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension |
| Q37370624 | Relationship of the 24-hour pattern of intraocular pressure with optic disc appearance in primary open-angle glaucoma |
| Q38128390 | Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy |
| Q50928525 | The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure. |
| Q50933377 | The Role of Beta-Adrenergic Receptors in the Regulation of Circadian Intraocular Pressure Rhythm in Mice. |
| Q35168230 | The pathophysiology and treatment of glaucoma: a review |
| Q37634184 | Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure |
| Q84977531 | Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry |
Search more.